Internal Medicine, Medical Oncology · Houston, TX
NPI
1588750095
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
278 services
Medicare patients, 2024
127
Average age 71
Drug cost, 2024
$1.2M
199 prescriptions
Company payments, 2025
$23K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shreyaskumar R Patel was code 99215 (office e&m - established), 148 times for 72 patients. In total Shreyaskumar R Patel billed 278 services in 15 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 148 | 72 | $101.67 | $15K |
| 99205 Office E&M - New | Facility | 17 | 17 | $117.92 | $2,005 |
| 99215 Office E&M - Established | Office | 16 | 12 | $136.47 | $2,184 |
By year: 2022 $28K for 279 services; 2023 $34K for 333 services; 2024 $27K for 278 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shreyaskumar R Patel prescribed most often to Medicare patients was Imatinib Mesylate, with 31 prescriptions and refills. In total Shreyaskumar R Patel wrote 199 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 31 | 47 | Under 11 | $140K |
| Stivarga Regorafenib | 17 | 17 | Under 11 | $433K |
| Loperamide Loperamide Hcl | 15 | 15 | Under 11 | $229 |
| Sunitinib Malate Generic | 14 | 14 | Under 11 | $112K |
| Ondansetron Hcl Generic | 13 | 13 | Under 11 | $53.96 |
| Daptomycin Generic | 11 | 11 | Under 11 | $72K |
Brand drugs: 40 claims; generic drugs: 159 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shreyaskumar R Patel $23K ($23K in general payments such as food, travel and fees) from 6 companies. The largest payer was Daiichi Sankyo Inc. with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.